Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 | 6.34% | 0 | 65.04% | 2.75% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 5.66% | 0 | 84.19% | 4.00% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5.52% | 0 | 89.57% | 4.40% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 4.66% | 0 | 89.33% | 2.20% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4.47% | 0 | 99.01% | 3.00% | 2025-11-20 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4.25% | 0 | 97.70% | 3.10% | 2027-05-17 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 3.99% | 0 | 79.96% | 1.70% | 2038-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | 3.02% | 0 | 92.31% | 1.38% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2.90% | 0 | 90.68% | 0.00% | 2028-09-23 | 1.85 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2.56% | 0 | 93.72% | 0.63% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2.50% | 0 | 96.70% | 1.13% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2.44% | 0 | 98.69% | 1.63% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
1.39% | 0 | 108.32% | 1.85% | 2049-06-18 | 190 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
1.39% | 0 | 105.81% | 1.85% | 2040-06-18 | 280 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
1.34% | 0 | 97.42% | 1.05% | 2035-05-11 | 325 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
1.24% | 0 | 104.26% | 1.75% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.97% | 0 | 98.46% | 0.63% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.79% | 0 | 101.81% | 1.60% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
0.43% | 0 | 99.97% | 0.25% | 2025-05-13 | 500 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | — | 4 M | 83.00% | 3.70% | 2042-09-21 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | — | 2.97 M | 97.30% | 4.00% | 2031-09-18 | 850 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | — | 13.01 M | 95.37% | 4.20% | 2034-09-18 | 1.1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | — | 1.84 M | 90.46% | 4.70% | 2054-09-18 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | — | 9.11 M | 97.67% | 3.80% | 2029-09-18 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
— | 0 | 103.54% | 1.65% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | — | 2.82 M | 96.08% | 2.00% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |